WP Domus

Bausch + Lomb is a leading global eye health company dedicated to helping people see better to live better. Its comprehensive portfolio includes over 400 products across three main business segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. With a history dating back to 1853, the company is a pioneer in the industry, having introduced the first soft contact lenses and numerous innovative ophthalmic treatments. Today, Bausch + Lomb continues to advance eye care through a robust pipeline of small molecules and medical devices targeting conditions such as dry eye, glaucoma, and retinal diseases. The company operates as a publicly traded entity, though it remains majority-owned by Bausch Health Companies following its 2022 IPO.